A 64-year-old man ingested about 60 ml 2% of topical minoxidil solution in order tomake his hair grow faster. Twelve hours after ingestion he was brought to the University Clinic of Toxicology with severe hypotension, tachycardia, chest pain and subendocardial ischemia. ECG showed diffuse T-wave inversion and depressed ST segments. He was also oligoanuric at admission. In spite of the intensive hydration with crystalloidsolutions and intravenous dopamine administrationthat resulted in partial hemodynamic improvement and resolution of the ECG changes, kidneyfailure occurred. After two hymodialysis sessions, urea and creatinine levels returned to normal and rebound hypertension appeared. The patient was discharged after 12 days of hospitalization in a good condition. Topical minoxidilsolution is formulation used for treatment of androgenic alopecia. If orally ingested it leads to severe hypotension, acute coronary syndrome, compensatory tachycardia and acute kidneyfailure. Emergency therapeutic approach is a precondition for successful outcome.
Introduction
Minoxidil is a known antihypertensive drug, which has recently been approved for treatment of androgenic alopecia. It can be found on the market as 5% and 2% solution. Sixty ml of 2% solution contains about 1,200 mg of minoxidil, which is approximately 12 times greater than the maximum recommended daily dose for controlling hypertension. Correlation between minoxidil in gestion and development ofsubendocardial ischemia, hemodynamic impairment and acute kidney failure (AKF) will be discussed in this paper.
Case report
A 64-year-old man with no prior history of kidney failure and cardiologic diseases was brought as an emergency case into the University Clinic of Toxicology 12 hourspost-ingestion of 60 ml 2% of minoxidil solution (Pilfud, Bosnalijek). He ingested the solution in order to achieve rapid therapeutic effects. He denied use of alcohol or other medications, but said he suffered from a moderate hypertension. On admission he was conscious, orientedto time and place, afebrile, eupneic. His pulse was 110/min, and blood pressure was 60/20 mmHg. The patient experienced chest pain, epigastric discomfort, weakness and malaise. ECG showed tachycardia and signs of subendocardial ischemia. Therapy was initiated with resuscitation with 2.5 literof physiological solution given in the first 7 hours, but the patient was anuric. Following administration of 8 mcg/kg/min dopamine the blood pressure increased to 90/60 mmHgat 12 hours after admission, and at 24 hours it reached and remained at 100/70 mmHg in the first three days. The dose of dopamine was gradually reduced to 2 mcg/kg and discontinued after 48 hours. Diuresis was 100/300/700 ml/24 hours on the first/second/third day, respectively, but the values of degradation products increased. The 130/80 Values of CK, CK-MB, urea, creatinine are expressed in mmol/l, dieresis in ml/24h, blood pressure in mm Hg. *hemodialysis patient underwent two hemodialysis sessions on the third and fourth day, which resulted in a polyuric phase and decrease of urea and creatinine. Blood pressure started to increase and since the fourth day until the end of the hospital stay ranged from 150/85 to 200/130 mmHg (rebound hypertension). Laboratory analysis showed leukocytosis, increase of CK (creatine kinase) and CK-MB, which did not surpass 10% of the CK value, and troponine was negative. Urea and creatininepeaked at36.5 mmol/l and 757 mmol/l, respectively, on the third day and returned to normal on the 10th day. The remaining laboratory findings were unspecific ( Table 1) . The first day ECG revealed diffusely inverted T-waves with depressed ST segments in V2-V6. These changes withdrew and ECG stabilized on the third day ( Figure  1, Figure 2) . 
Discussion
Minoxidil, which was originally used for treatment of hypertension, recently has been approved for treatment of male pattern baldness [1] . Adverse effects of minoxidil local application are rare and minor. Most commonly it can cause itching and irritation on the affectted area and other dermatologic complications and minor systemic effects due to its small resorption. The systemic application of minoxidil is associated with more serious complications. Minoxidil is activated in the liver and its action isto relax vascular smooth muscle by opening cell surface potassium channels causing an efflux of potassium, hyperpolarization and relaxation of smooth muscle cells. Minoxidilproduces systemic hypotension by a direct arteriolar vasodilatation and is associated with a reflex increase in cardiac output and myocardial contractility mediated by the sympathetic nervous system. Maximal concentration in the blood is achieved 1 hour after oral administration, but due to delay of active metabolic for-mation, the maximal therapeutic effect appears much later. The serum half-life is 3 to 4 hours, but the effect can last 24 hours or longer [2] . Minoxidil is eliminated mainly by hepatic metabolism. There are reports thatminoxidil does not cause hypotension in normotensive individuals [3] . However, many authors report prolonged hypotension post-ingestion, which lasts two to four days after admission to the hospital [4, 5] . Various cardiovascular manifestations resulting from different doses of minoxidil have been reported. Lower doses produce hypotension and successive increase in doses leads to tachycardia and myocardial ischemia. This tachycardia and resultant myocardial ischemia are probably a compensatory mechanism for severe hypotension. These cases are treated with combination of crystalloids, dopamine [6] and phenylephrine infusion [7] guided by the cardiovascular parameters. The greater the contractility, the more oxygen the myocardium consumes. Increased heart rate (HR) leads to increased myocardial O2 consumption. In our patient, in addition to prolonged hypotension and tachycardia coronary syndrome developed along with reverse ECG changes and negative CK-MB and troponine. Subendocardial ischemia is believed to be caused by an increased myocardial oxygen demanddue to secondary catecholamine overload that increases myocardial contractilityand decreasedcoronary perfusion that is due to tachycardia and hypotension acute minoxidil intoxication. Similar transitory ECG changes when larger doses of minoxidil (about 3 grams) had been given were described by other authors [8, 9] . Some authors have presented development of nontransmural infarction as a result of ingestion of similar amount of minoxidil solution, associated with pleural effusion and good response to conservative treatment [7] . Besides coronary syndrome, the patient developed AKF that did not respond to the conservative treatment, but hemodialysis was required for returning the degradation products to normal values. In our patient the cause for kidney failure was dishemodynamicand was probably a result of delayed hospitalization (12 hours post-ingestion) and prolonged kidney hypoperfusion. In other case reports a smaller degree of oliguria was registered as well as a smaller increase in degradation products with more rapid response to drug treatment as a result of the urgent hospitalization (two hours post-ingestion at the most) [5, 7, 9] . There is a lack of literature on minoxidil direct nephrotoxicity that results in decreased kidney function in a state of acute overdosage. Therefore, we assume there was a preranal failure in our patient, which was caused by hemodynamic insufficiency and suffered renal hypoxia. The so-called rebound hypertension was registered in our patient, which appeared on the 4 th day of the hospital stay, that is, following hemodialysis and establishment of diuresis.
By definition rebound hypertension is an increase in blood pressure in response to stopping or reducing high blood pressure medication. Severe cases can result in a very large increase in blood pressure which requires prompt treatment to avoid complications such as organ damage. Hypertension in our patient was a result of blood pressure establishing without therapy, when minoxidil, which is dialyzable, was completely eliminated and kidney function was improved. Althoughprazosin was included in the therapy on the seventh day, peak value was reached on the 10 th day of hospitalization (200/130 mmHg), and it returned to normal until the discharge day by dose adjustmentof prazosin in the therapy. There are no case reports in the literature presenting with rebound hypertension after minoxidil intoxication. However, this phenomenon has been described in children treated with several hypertensive drugs after discontinuation of minoxidil therapy due to the development ofhypertrichosis. Rebound hypertension was manifested with hypertensive encephalopathy in those children in whom minoxidil was withdrawn rapidly. The occurrence ofrebound hypertension correlated well with the cumulative dose of minoxidil and the rapidity with which minoxidil was withdrawn [10] . Thus, we think this phenomenon can appear also in patients intoxicated with minoxidil, who had a history of hypertension and can be an additional risk factor for onset of other co-morbidities if it is not expected and not treated. In summary, we have presented a case of severe poisoning after ingestion of 2% of topical minoxidil solution. This is the first case in our clinical practice, which was manifested with severe hypotension, tachycardia, subendocardial ischemia, AKF and rebound hypertension. As the use and availability of these solutions for local application is increasing, a greater awarenessof systemic toxic effect of minoxidil is also necessary as well as immediate and adequate treatment.
